Please login to the form below

Not currently logged in
Email:
Password:

Alkindi

This page shows the latest Alkindi news and features for those working in and with pharma, biotech and healthcare.

Diurnal files adrenal insufficiency drug Alkindi in US

Diurnal files adrenal insufficiency drug Alkindi in US

Could become only treatment for children with the condition. UK specialty drugmaker Diurnal has filed its Alkindi Sprinkle replacement therapy for children with adrenal insufficiency in the US, a group with ... The two halves of the Alkindi capsules are

Latest news

  • Resurgent Diurnal raises £5.4m for twin product filings Resurgent Diurnal raises £5.4m for twin product filings

    Both should be submitted before the end of the year. The funds will also be used to boost Diurnal’s European sales capacity as it continues to roll out Alkindi in ... Europe after its approval by the EMA last year, and to pursue licensing deals for

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...

Infographics